Skip to content

The Benefits of Hemp Protein Supplementation During Resistance Training

The Benefits of Hemp Protein Supplementation During Resistance Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02529917
Enrollment
34
Registered
2015-08-20
Start date
2015-08-31
Completion date
2015-12-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Brief summary

Forty physically active men and women aged 18-45y will take part in an 8-week resistance training program, randomized (double blind) 1:1 into each of two groups. Twenty participants will be randomized to receive 60 g/d of hemp powder (containing approximately 40 g protein and 9 g oil) supplementation and 20 randomized to receive 60 g/d of soy supplementation (matched to the hemp for macronutrients and calories) during eight weeks of training. Each participant will complete testing before and after the intervention for assessment of body composition (lean tissue, fat, and bone mass), strength, central fatigue, markers of inflammation, and bone resorption. Over the 8-weeks of training, participants will train four-five days per week for 1-1.5 hours per session with exercises targeting all major muscle groups. The training will involve a two day split where different muscle groups are trained on two consecutive days (day 1 involves chest, back, and arms; day 2 legs, shoulders, and abdominals). Resistance training will provide the necessary stimulus for protein synthesis to optimize the effect of a protein-containing nutritional supplement. The hemp or soy powder will be consumed in two doses (i.e. 30 g powder containing 20 g protein per dose) immediately after exercise sessions and one hour after exercise. This dosing regimen is optimal for stimulating muscle protein synthesis and building muscle mass . On the one non-training day per week the two doses will be consumed with meals.

Interventions

DIETARY_SUPPLEMENTHemp powder

Hemp powder supplement

DIETARY_SUPPLEMENTSoy Powder

Soy powder supplement

Sponsors

University of Saskatchewan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* At least 6 months experience with resistance training

Exclusion criteria

* Allergies to hemp or soy * Consumption of other nutritional supplements in previous month * Answered yes to questions on the Physical Activity Readiness Questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Change in lean tissue mass (kg)8 weeksLean tissue mass measured with dual energy x-ray absrorptiometry

Secondary

MeasureTime frameDescription
Change in bone mass (grams)8 weeksBone mass as measured by dual energy x-ray absorptiometry
Change in elbow flexor muscle thickness (cm)8 weeksMuscle thickness as assessed by ultrasound
Change in knee extensor muscle thickness (cm)8 weeksmuscle thickness as measured by ultrasound
Change in bench press strength (kg)8 weeksBench press strength as assess on a plate-loaded machine by the 1-RM method
Change in arm curl strength (kg)8 weeksArm curl strength as assessed with dumbbells by the 1-RM method
Change in fat mass (kg)8 weeksFat mass as measured by dual energy x-ray absorptiometry
Change in inflammation by interleukin-6 (mmol/l) levels8 weeksInterleukin-6 levels measured from saliva samples
Change in inflammation by C-reactive protein (mmol/l) levels8 weeksC-reactive protein levels measured from saliva samples
Change in bone resorption (N-telopeptides) (mmol/l)8 weeksN-telopeptides measured from urine samples
Change in voluntary muscle activation (Nm)8 weeksVoluntary muscle activation as measured by the interpolated twitch technique
Change in leg press strength (kg)8 weeksLeg press strength as assessed on a leg-press machine by the 1-RM method

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026